publicações selecionadas
-
artigo académico
- Multifunctional Hyaluronic Acid/Graphite Nanoplatelet Hydrogels as Tools for Spinal Cord Regeneration. ACS Applied Materials and Interfaces. 2025
- Bioadhesive Hyaluronic Acid-Based Hydrogels for Spinal Cord Injury. Biomacromolecules. 2024
- Adhesive and Antibacterial Films Based on Marine-Derived Fucoidan and Chitosan. ACS Sustainable Chemistry and Engineering. 2022
- Adhesive and biodegradable membranes made of sustainable catechol-functionalized marine collagen and chitosan. Colloids and Surfaces B: Biointerfaces. 2022
-
documento
- Dopamine-functionalized hyaluronic acid hydrogels as tissue adhesives for anti-inflammatory delivery in neural tissue applications 2025
- Dopamine-functionalized hyaluronic acid hydrogels for anti-inflammatory delivery in neural tissue applications 2025
- Adhesive and biodegradable membranes from marine origin raw materials for soft tissue engineering 2023
- Marine-based biodegradable films with antibacterial and adhesive properties 2023
- Adhesive and antibacterial membranes from marine-derived fucoidan and chitosan 2022
- Bioadhesive hydrogels based on Hyaluronic acid for spinal cord regeneration 2022
- Chitosan hydrogels Inspired by mussels with superior adhesion for bone tissue regeneration 2022
- Hydrogels based on catechol-modified hyaluronic acid combined with graphene derivatives for biomedical applications 2021
- Injectable thermosensitive catechol-modified chitosan hydrogels with superior adhesion for bone tissue regeneration 2021
- Marine origin membranes based on chitosan and collagen 2021
- Production and characterization of tissue adhesives for Gastrointestinal repair 2019
- Production of tissue adhesives based on marine-derived materials for Gastrointestinal repair 2019
- Synthesis, molecular Docking and biological evaluation of new 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenylureas as Potent Type II VEGFR-2 Tyrosine Kinase inhibitors 2014
- Epidermal growth factor receptor inhibitory activity of new potential antitumor di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series 2013
- New di(heteroaryl)thioethers 1,3-diarylureas in the thieno[3,2-b]pyridine series as VEGFR2 tyrosine kinase inhibitors: docking, synthesis, enzymatic and cellular assays 2013
- Synthesis and evaluation of the antitumor potential of new aminated or methoxylated di(hetero)arylthioethers in the thieno[3,2-b]pyridine series 2013
- Synthesis of new N-[3-(thieno[3,2-b]pyridine-7-ylthio)phenyl]benzamides as potential inhibitors the tyrosine kinase domain of VEGFR2 2013
- Synthesis, growth inhibitory activity on human tumor cell lines and evaluation of the hepatotoxicity of di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series. 2012
- 1-Aryl-3-[4-(thieno[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as VEGFR2 tyrosine kinase inhibitors: synthesis, docking studies, enzymatic and cellular assays 2012
- Heteroarylether 1,3-diarylureas in the thieno[3,2-d]pyrimidine series as VEGFR2 tyrosine Kinase inhibitors: synthesis, docking studies, enzymatic and cellular assays 2012
- Synthesis of novel 1-aryl-3-[2,3- or 4-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas and evaluation as VEGFR2 tyrosine kinase inhibitors 2012
- Thieno[3,2-b]pyridine arylethers: synthesis and growth inhibitory activity on human tumor cell lines 2012
- Methyl 3-[4-(3-arylureido)phenylamino]thieno[3,2-b]pyridine-2-carboxylates as potential inhibitors of VEGFR-2: synthesis and molecular modelling studies 2011